16 mg buprenorphine with 4 mg naloxone sublingual film
71936002
Approved other terminated
Quick answer
16 mg buprenorphine with 4 mg naloxone sublingual film for Evaluation of QTc Interval is a Approved program (other) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Evaluation of QTc Interval
- Phase
- Approved
- Modality
- other
- Status
- terminated